News Medical

Invitae announces dramatic expansion of genetic testing menu

Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin ...
The Business Journals

Invitae's $239 million sale to Labcorp approved by Bankruptcy Court

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae filed for Chapter 11 ...
News Medical

Invitae launches new education program to increase awareness of genetic testing for ...

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 ...
The Business Journals

Labcorp takes over Bay Area pioneer in genetic testing but remains hush on plans

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae cut about 1,000 jobs ...
Seeking Alpha

Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of ...

SAN FRANCISCO, Jan. 30, 2024 /PRNewswire/ -- Invitae (NVTA) (NYSE: NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (BBIO), a commercial-stage ...